ID: ALA473129

Max Phase: Preclinical

Molecular Formula: C22H24FNO2

Molecular Weight: 353.44

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(c1ccc(F)cc1)C1CCN([C@@H]2Cc3ccccc3C[C@H]2O)CC1

Standard InChI:  InChI=1S/C22H24FNO2/c23-19-7-5-15(6-8-19)22(26)16-9-11-24(12-10-16)20-13-17-3-1-2-4-18(17)14-21(20)25/h1-8,16,20-21,25H,9-14H2/t20-,21-/m1/s1

Standard InChI Key:  NIXIHSCMKWWEOU-NHCUHLMSSA-N

Associated Targets(Human)

Vesicular acetylcholine transporter 269 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Sigma-1 receptor 3326 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Vesicular acetylcholine transporter 105 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Vesicular acetylcholine transporter 102 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Sigma opioid receptor 1607 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 353.44Molecular Weight (Monoisotopic): 353.1791AlogP: 3.25#Rotatable Bonds: 3
Polar Surface Area: 40.54Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.52CX LogP: 3.64CX LogD: 2.49
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.86Np Likeness Score: -0.29

References

1. Tu Z, Efange SM, Xu J, Li S, Jones LA, Parsons SM, Mach RH..  (2009)  Synthesis and in vitro and in vivo evaluation of 18F-labeled positron emission tomography (PET) ligands for imaging the vesicular acetylcholine transporter.,  52  (5): [PMID:19203271] [10.1021/jm8012344]
2. Tu Z, Efange SM, Xu J, Li S, Jones LA, Parsons SM, Mach RH..  (2009)  Synthesis and in vitro and in vivo evaluation of 18F-labeled positron emission tomography (PET) ligands for imaging the vesicular acetylcholine transporter.,  52  (5): [PMID:19203271] [10.1021/jm8012344]
3. Tu Z, Efange SM, Xu J, Li S, Jones LA, Parsons SM, Mach RH..  (2009)  Synthesis and in vitro and in vivo evaluation of 18F-labeled positron emission tomography (PET) ligands for imaging the vesicular acetylcholine transporter.,  52  (5): [PMID:19203271] [10.1021/jm8012344]
4. Li J, Zhang X, Zhang Z, Padakanti PK, Jin H, Cui J, Li A, Zeng D, Rath NP, Flores H, Perlmutter JS, Parsons SM, Tu Z..  (2013)  Heteroaromatic and aniline derivatives of piperidines as potent ligands for vesicular acetylcholine transporter.,  56  (15): [PMID:23802889] [10.1021/jm400664x]
5. Barthel C, Sorger D, Deuther-Conrad W, Scheunemann M, Schweiger S, Jäckel P, Roghani A, Steinbach J, Schüürmann G, Sabri O, Brust P, Wenzel B..  (2015)  New systematically modified vesamicol analogs and their affinity and selectivity for the vesicular acetylcholine transporter - A critical examination of the lead structure.,  100  [PMID:26071858] [10.1016/j.ejmech.2015.05.033]

Source